RPG Life Sciences Limited Financial Statements

RPG Life Sciences Limited (RPGLIFE) reported revenue of ₹6.66B in FY2025 with net income of ₹1.83B. Total assets stood at ₹6.58B and free cash flow was ₹418.30M.

RPG Life Sciences Limited Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		3.90B	4.43B	5.18B	5.89B	6.66B
Cost of Rev. Cost of Revenue		-1.31B	-1.42B	-1.71B	-1.85B	-2.14B
Gross Profit		2.59B	3.01B	3.47B	4.05B	4.52B
SGA Sales, General & Admin		-1.88B	-2.12B	-2.39B	-2.69B	-2.80B
Op. Income Operating Income		543.70M	736.90M	919.90M	1.18B	1.51B
PBT Profit Before Tax		535.80M	731.70M	916.80M	1.18B	2.33B
Net Income		400.00M	514.80M	676.40M	876.60M	1.83B
Dil. Shares Diluted Shares		16.54M	16.54M	16.54M	16.54M	16.54M
Diluted EPS		24.19	31.13	40.90	53.01	110.80

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows RPG Life Sciences Limited's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

RPG Life Sciences Limited Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		1.76B	2.07B	2.64B	2.98B	4.65B
Non-curr. assets Total non-current assets		1.28B	1.38B	1.55B	2.15B	1.93B
Total assets		3.03B	3.45B	4.19B	5.13B	6.58B
Curr. liabilities Total current liabilities		796.90M	801.10M	1.03B	1.31B	1.20B
Non-curr. liab. Total non-current liabilities		72.50M	87.30M	89.70M	70.60M	74.50M
Total liabilities		869.40M	888.40M	1.12B	1.38B	1.27B
Total equity		2.16B	2.56B	3.08B	3.75B	5.31B
Total liab. & eq. Total liabilities & equity		3.03B	3.45B	4.19B	5.13B	6.58B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures RPG Life Sciences Limited's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

RPG Life Sciences Limited Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		535.80M	731.70M	916.80M	1.18B	2.33B
Operating CF Cash flow Operating Activities		582.70M	647.50M	908.20M	943.60M	778.60M
Capex Investments in PPE		-85.10M	-239.50M	-327.30M	-692.30M	-360.30M
Investing CF Cash flow Investing Activities		-79.60M	-346.60M	-1.06B	-791.50M	-418.00M
Dividend Paid		0	-119.10M	-158.80M	-198.50M	-264.60M
Financing CF Cash flow Financing Activities		-104.90M	-135.10M	-171.20M	-203.10M	-270.80M
Cash (start) Cash at beginning of period		5.40M	403.60M	569.40M	248.20M	197.20M
Cash (end) Cash at end of period		403.60M	569.40M	248.20M	197.20M	287.00M
FCF Free Cash Flow		497.60M	408.00M	580.90M	251.30M	418.30M

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how RPG Life Sciences Limited's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025